Blood Pressure Monitor TH-75 Atrial Fibrillation Detection Function Clinical Trial

What this Trial Is About

Researchers are evaluating how accurately the TH-75 blood pressure monitor detects atrial fibrillation AF by comparing its results to a standard diagnostic method. The study aims to determine if this device meets specific criteria for detecting AF in adults with and without the condition. This observational research is sponsored by Andon Health Co., Ltd and focuses on adults aged 22 years and older. Participants will use the TH-75 blood pressure monitor alongside electrocardiogram ECG tests to monitor heart rhythm. The study involves measuring arm circumference to ensure proper device fit, requiring participants to have an arm circumference between 22 cm and 42 cm. Both those diagnosed with atrial fibrillation and those without will be observed during the study period. Throughout the study, researchers will compare the blood pressure monitors detection accuracy against standard ECG results. Participants will undergo blood pressure measurements and ECG assessments as part of the evaluation. The primary outcome is the accuracy of atrial fibrillation detection by the TH-75 monitor, measured against predetermined acceptance criteria. The study is expected to complete by July 30, 2026.

Blood Pressure Monitor (TH-75) Atrial Fibrillation Detection Function Clinical Trial